TopFunds

Intuitive Surgical, Inc.

NASDAQ: ISRG

Stock price

426.7 USD

(+0%) TODAY

Medical - Instruments & SuppliesMedical - Devices
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.7
2.1
1.9
3.2
3.9
2.9
4.7
3.7
5
6.4
7.9
16.4%
02Free cash flow per share
2
2.8
2.7
2.8
3.3
3.2
4.7
2.6
2.1
3.6
6.9
13%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
2,384
2,704
3,129
3,724
4,479
4,358
5,710
6,222
7,124
8,352
10,065
15.5%
06% Change
-
-
-
-
-
-
-
-
-
-
-
15.5%
07Cost of revenue
(806.5)
(814.3)
(934.8)
(1,120)
(1,368)
(1,497)
(1,752)
(2,026)
(2,395)
(2,718)
(3,422)
15.6%
08Gross profit
1,578
1,890
2,194
2,604
3,110
2,861
3,959
4,196
4,730
5,634
6,642
15.5%
09% Margin
66.2%
69.9%
70.1%
69.9%
69.5%
65.7%
69.3%
67.4%
66.4%
67.5%
66%
68% A
10Operating expenses
(837.9)
(944.9)
(1,140)
(1,405)
(1,736)
(1,811)
(2,138)
(2,619)
(2,963)
(3,285)
(3,697)
16%
11% of Revenue
(35.1)%
(34.9)%
(36.4)%
(37.7)%
(38.8)%
(41.6)%
(37.4)%
(42.1)%
(41.6)%
(39.3)%
(36.7)%
(38.3)% A
12Operating Income
740
945.2
1,055
1,199
1,375
1,050
1,821
1,577
1,767
2,349
2,946
14.8%
13Income tax expense
(169.7)
(244.9)
(436.5)
(154.5)
(120.4)
(140.2)
(162.2)
(262.4)
(141.6)
(336.3)
(434.8)
9.9%
14Net Income
588.8
735.9
660
1,128
1,379
1,061
1,705
1,322
1,798
2,323
2,856
17.1%
15% Margin
24.7%
27.2%
21.1%
30.3%
30.8%
24.3%
29.9%
21.3%
25.2%
27.8%
28.4%
26.5% A
16Shares Outstanding
341.1
353.7
348.9
356.4
358.5
360.9
365.8
362
357.4
362
362.7
0.6%
17EPS Basic
1.8
2.1
2
3.3
4
3
4.8
3.7
5.1
6.5
8
16.4%
18EPS Diluted
1.7
2.1
1.9
3.2
3.9
2.9
4.7
3.7
5
6.4
7.9
16.4%
19EBITDA
829.5
1,042
1,162
1,322
1,578
1,326
2,201
1,973
2,414
3,136
3,989
17%
% Margin
34.8%
38.5%
37.1%
35.5%
35.2%
30.4%
38.5%
31.7%
33.9%
37.6%
39.6%
35.7% A
20Net Interest Income (expense)
18.5
35.6
41.9
80.1
127.7
157.2
69.3
29.7
192.1
324.9
365.9
34.8%
21Net Debt / EBITDA
(4)
(4.6)
(3.3)
(0.6)
(0.7)
(1.2)
(0.5)
(0.8)
(1.1)
(0.6)
(0.8)
(1.7) A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
3,348
4,838
3,847
857.9
1,168
1,623
1,291
1,581
2,750
2,027
3,368
0.1%
23Short-term investments
-
-
-
2,205
2,054
3,549
2,940
2,541
2,473
1,986
2,567
-
24Accounts receivable
394.3
430.2
507.9
682.3
708.3
726.6
893
1,073
1,268
1,357
1,628
15.2%
25Other current assets
73.5
83.3
57.3
178.8
137.1
126.3
133.9
168.6
176.7
253.7
376.4
17.7%
26Inventory
167.9
182.3
241.2
409
595.5
601.5
587.1
893.2
1,221
1,487
1,840
27.1%
27Total Current Assets
3,910
5,450
4,687
4,333
4,663
6,626
5,845
6,253
7,888
7,111
9,780
9.6%
Non-Current Assets
28Net property, plant & equipment
432.1
458.4
613.1
812
1,273
1,577
1,876
2,374
3,538
4,783
5,342
28.6%
29Long-term investments
1,788
2,283
1,886
1,771
2,624
1,758
4,416
2,624
2,120
5,065
3,299
6.3%
30Other non-current assets
(1,223)
(1,705)
(1,428)
930.2
1,174
1,208
1,418
1,723
1,896
1,880
2,211
-
31Total Non-Current Assets
997.3
1,037
1,071
3,514
5,071
4,543
7,710
6,721
7,554
11,728
10,852
27%
Total Assets
4,907
6,487
5,758
7,847
9,733
11,169
13,555
12,974
15,442
18,839
20,631
15.4%
LIABILITIES
Current Liabilities
32Accounts payable
52.6
68.5
82.5
100.7
123.5
81.6
121.2
147
188.7
193.4
255.1
17.1%
33Short-term debt
-
-
-
-
-
-
-
-
-
33.5
39
-
34Other current liabilities
535.2
640.6
948.7
719.9
906.7
883.6
1,029
1,275
1,470
1,518
1,712
12.3%
35Total Current Liabilities
587.8
709.1
1,031
820.6
1,030
965.2
1,150
1,422
1,659
1,745
2,006
13.1%
Non-Current Liabilities
36Long-term debt
-
-
-
-
-
-
87
-
-
112.5
263.8
-
37Other non-current liabilities
95.9
112.6
327.1
338.6
418.3
444.6
366.7
439.3
385.5
451.2
419.5
15.9%
38Total Non-Current Liabilities
95.9
112.6
327.1
338.6
418.3
444.6
453.7
439.3
385.5
563.7
683.3
21.7%
39Total Liabilities
587.8
709.1
1,031
1,159
1,449
1,410
1,604
1,861
2,044
2,309
2,690
16.4%
SHAREHOLDERS` EQUITY
40Common stock
-
-
0.1
0.1
0.1
0.1
0.4
0.4
0.4
0.4
0.4
-
41Retained earnings / (deficit)
899.2
1,575
61.4
1,522
2,495
3,261
4,761
3,500
4,743
6,803
7,012
22.8%
42Accumulated other comprehensive income / (loss)
(9.5)
(8.9)
(15.5)
(13.3)
12.4
24.9
(24.2)
(162.5)
(12.2)
(51.3)
43.3
-
43Noncontrolling interests
-
-
1.6
8.7
20.9
27.6
50.4
70.7
89.7
95.9
117.7
-
44Total shareholders' equity
4,320
5,778
4,728
6,688
8,306
9,787
12,002
11,113
13,397
16,530
17,942
15.3%
45Total Liabilities and shareholders' Equity
4,907
6,487
5,758
7,847
9,733
11,169
13,555
12,974
15,442
18,839
20,631
15.4%
46Total Debt
-
-
-
-
76.4
-
87
-
-
146
302.8
-
47Net Debt
(3,348)
(4,838)
(3,847)
(857.9)
(1,091)
(1,623)
(1,204)
(1,581)
(2,750)
(1,881)
(3,065)
(0.9)%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
588.8
735.9
660
1,128
1,379
1,061
1,705
1,322
1,798
2,323
2,856
17.1%
49Depreciation & amortization
89.5
92.1
99.1
122.8
203
276.2
310.2
365.8
454.8
462
677.1
22.4%
50Share-based compensation expense
167.9
177.6
209.1
261.2
335.8
395.4
449.2
513.2
598.2
676.8
788.2
16.7%
51Changes in working capital and other assets
(74.3)
37.3
175.7
(342.3)
(319.9)
(247.4)
(374.6)
(710.5)
(1,037)
(1,046)
(1,291)
33%
52Net cash flows from operating activities
771.9
1,043
1,144
1,170
1,598
1,485
2,089
1,491
1,814
2,415
3,031
14.7%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(81)
(53.9)
(190.7)
(187.4)
(425.6)
(341.5)
(353.5)
(532.4)
(1,064)
(1,111)
(539.8)
20.9%
54Purchases of investments / marketable securities
(1,827)
(2,586)
(1,995)
(2,582)
(3,346)
(4,293)
(6,452)
(1,400)
(2,207)
(5,140)
(1,216)
(4)%
55Proceeds from maturities of marketable securities
1,059
1,360
2,564
1,808
2,677
3,732
4,353
3,316
2,920
2,979
2,435
8.7%
56Other investing activities
-
-
-
(87.9)
(59.7)
(37.7)
(8.7)
(12.8)
(8.9)
(1)
(13.9)
-
57Net cash flows from investing activities
(849.5)
(1,279)
378.7
(1,050)
(1,154)
(940.6)
(2,462)
1,371
(360.1)
(3,273)
665.8
-
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
177.4
538.4
(1,859)
236.6
(269.5)
174.5
276.5
(2,607)
(120)
429.4
(1,945)
-
59Dividends paid, net
-
-
-
-
-
-
-
-
-
-
-
-
60Debt issuance (repayments), net
-
-
-
-
-
-
-
-
-
-
-
-
61Other financing activities
16
20.1
(54.6)
(110.3)
101.1
(260.2)
(233.5)
35.1
(167.6)
(278.5)
(419.1)
-
62Net cash flows from financing activities
193.4
558.5
(1,913)
126.3
(168.4)
(85.7)
43
(2,572)
(287.6)
150.9
(2,364)
-
63Increase (decrease) in cash and cash equivalents
114.3
322
(388.4)
246.2
273.2
455.9
(332.5)
294.7
1,169
(707.7)
1,345
28%
64Cash and equivalents, ending balance
714.6
1,037
648.2
909.4
1,183
1,639
1,306
1,601
2,770
2,062
3,407
16.9%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
690.9
989
953.2
982.2
1,173
1,143
1,736
958.4
749.6
1,304
2,491
13.7%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Intuitive Surgical, Inc. (ISRG) financial statements and performance

Explore Intuitive Surgical, Inc. (ISRG) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.